Page 389 - IJB-9-2
P. 389

International Journal of Bioprinting                               In situ 3D bioprinter for skin wound healing



            even certain improvement in the dynamics of this process strongly suggests that in situ bioprinting could be used as a
            novel therapeutic modality in wound healing.


            Keywords: In situ bioprinting; Wound healing; Bioink; Collagen hydrogel



            1. Introduction                                    2. Materials and methods
            Bioprinting is defined as a robotic layer by layer or additive   2.1. Hardware
            biofabrication of functional tissue and organ constructs from   The in situ printing scheme on a living organism includes
            living cells and biomaterials (usually hydrogel) according to   a robotic arm KUKA Sunrise Cabinet (KUKA, Germany)
            digital model [1-6] . To perform bioprinting, it is necessary to   that performs flexible programming in a high-level Java
            have digital model of tissue and organ construct, bioink, or   language (Figure  1). An extruder based on an electric
            hydrogel loaded with living cells and bioprinter [7-9] . Due to its   motor for hydrogel extrusion was used, since it is more
            relative anatomical and histological simplicity, bioprinting   convenient to use and does not require a compressor for
            of human skin became one of most popular topics in the   compressed air. In addition, the scheme uses a real-time
            rapidly emerging bioprinting research field [10-12] . There are   breathing skin displacement sensor, a robot controller
            two main approaches in skin bioprinting technology: (i) In   and a personal computer (PC)  (Figure  2). In this  case,
            vitro bioprinting and (ii) in situ bioprinting. In the first case,   the computer and the end effector are connected through
            skin construct must be at first bioprinted in clean room or in   USB, as well as the computer and the robot controller are
            so-called good manufacturing practice (GMP) facilities and   connected through TCP/IP protocol.
            during post-processing, bioprinted skin constructs must
            undergo accelerated tissue maturation in specially designed   The compact structure of the end effector consists
            bioreactor [13-15] .  In  case  of  so-called  in situ  (or  in vivo  or   of a cooling system, a controller of the end effector, a
            intraoperational) bioprinting, biofabrication of human skin   Fishman dispenser, and a biomaterial (Figure  3A). The
            could be performed directly on the patient body in operating   compactification of the technical solution was achieved
            room and it does not require GMP facilities. Moreover,   by placing the entire electrical part on the end effector in
            human body will serve as some sort of bioreactor, and thus,   the control unit. All electrical components, such as voltage
            there is a need in specially designed bioreactor. Thus, in situ   converters, a stepper motor control driver, and a control
            skin bioprinting has certain advantage and represent a cost-  microcontroller of the end effector, were attached to the main
            effective alternative as compared with more conventional   body of the control unit. The block was closed with a lid from
            in vitro skin bioprinting [16-21] . Robotic bioprinter is a key   above (Figure 3B), which provided the protective properties
            element  of  bioprinting  system.  There  are  already  several   of  electrical  components  from  external  environmental
            dozen companies producing commercial  in vitro three-  influences. The housing and holder of the dispenser itself,
            dimensional (3D) bioprinters  and even first attempts to   which attached the end effector to the flange of the robot
                                   [22]
            develop original custom made in situ bioprinter in academic   (Figure 3B), was made by FDM using the Ultimaker 2 3D
            setting [23-25]  but, to the best of our knowledge, there are   printer (Ultimaker B.V., Netherlands). The structure also
            commercially available in situ bioprinter. On the other hand,   includes several programmable devices: A robot controller,
            there is a growing interest to develop relatively cheap and   an end effector, and a PC. At the same time, it is worth
            affordable  in situ handheld printers [26-30]  which, however,   noting that communication and management of all devices
            are inferior option because they are not robotic driven and   in the system were facilitated with the help of a PC.
            thus do not follow specially designed digital models. The   The  choice  of  the  dispenser  is  due  to  the  fact  that  it
            purpose of this work was to describe the design, fabrication,   has already been used in the 3D bioprinter Fabion (3D
            and initial in vitro and in vivo testing of in situ 3D bioprinter.   Bioprinting Solution, Russia) and has proven itself to be
            To the best of our knowledge, this is the first description of   a convenient and reliable  dispenser of biomaterials. An
            commercially available commercial articulated collaborative   important advantage is the possibility of flexible controlled
            3D bioprinter suitable for in situ skin bioprinting. Pre-clinical   material supply. The stem tip has a screw thread into
            testing on specially designed animal models of human skin   which the syringe piston is screwed, which allows both
            diseases and sequential certification and regulatory agencies   extrusion and suction of the material and is very important
            approval for clinical use will enable highly desirable clinical   when working with viscous materials having inertia. The
            translation and commercialization of this technology.  dispenser squeezes out the material using a stepper motor,



            Volume 9 Issue 2 (2023)                        381                      https://doi.org/10.18063/ijb.v9i2.675
   384   385   386   387   388   389   390   391   392   393   394